Literature DB >> 16103612

Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001-2002.

Linda J Demma1, Robert C Holman, Jennifer H McQuiston, John W Krebs, David L Swerdlow.   

Abstract

During 2001 through 2002, 1,176 cases of the tick-borne diseases human monocytic ehrlichiosis (HME) and human granulocytic anaplasmosis (HGA) were reported to the Centers for Disease Control and Prevention (CDC) by 32 states through the National Electronic Telecommunications System for Surveillance. The average reported annual incidences for HME and HGA during 2001-2002 were 0.6 and 1.4 cases per million population, respectively; incidence was highest among men > 60 years of age. During this same interval, a total of 883 cases of HME and HGA were reported to CDC through a passive surveillance system of tick-borne disease case report forms (CRFs). The surveillance information retrieved from CRFs has allowed for qualitative evaluation of ehrlichiosis and anaplasmosis risk factors, severity, and diagnostic accuracy. Although these surveillance systems likely substantially under-represent the true burden of ehrlichiosis and anaplasmosis in the United States due to poor recognition and reporting, they represent the first compilation of national data since these diseases were made nationally notifiable. Continued and improved surveillance activities will progressively reinforce our understanding and awareness of these newly recognized zoonotic infections.

Entities:  

Mesh:

Year:  2005        PMID: 16103612

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  38 in total

1.  The prevalence of zoonotic tick-borne pathogens in Ixodes scapularis collected in the Hudson Valley, New York State.

Authors:  Matthew T Aliota; Alan P Dupuis; Michael P Wilczek; Ryan J Peters; Richard S Ostfeld; Laura D Kramer
Journal:  Vector Borne Zoonotic Dis       Date:  2014-04-01       Impact factor: 2.133

2.  Emergence of a new pathogenic Ehrlichia species, Wisconsin and Minnesota, 2009.

Authors:  Bobbi S Pritt; Lynne M Sloan; Diep K Hoang Johnson; Ulrike G Munderloh; Susan M Paskewitz; Kristina M McElroy; Jevon D McFadden; Matthew J Binnicker; David F Neitzel; Gongping Liu; William L Nicholson; Curtis M Nelson; Joni J Franson; Scott A Martin; Scott A Cunningham; Christopher R Steward; Kay Bogumill; Mary E Bjorgaard; Jeffrey P Davis; Jennifer H McQuiston; David M Warshauer; Mark P Wilhelm; Robin Patel; Vipul A Trivedi; Marina E Eremeeva
Journal:  N Engl J Med       Date:  2011-08-04       Impact factor: 91.245

3.  Increasing incidence of Ehrlichia chaffeensis and Anaplasma phagocytophilum in the United States, 2000-2007.

Authors:  F Scott Dahlgren; Eric J Mandel; John W Krebs; Robert F Massung; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

4.  Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts.

Authors:  Ana A Weil; Elinor L Baron; Catherine M Brown; Mark S Drapkin
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

5.  Prevalence of human-active and variant 1 strains of the tick-borne pathogen Anaplasma phagocytophilum in hosts and forests of eastern North America.

Authors:  Felicia Keesing; Diana J McHenry; Michelle Hersh; Michael Tibbetts; Jesse L Brunner; Mary Killilea; Kathleen LoGiudice; Kenneth A Schmidt; Richard S Ostfeld
Journal:  Am J Trop Med Hyg       Date:  2014-05-27       Impact factor: 2.345

6.  Identification of novel surface proteins of Anaplasma phagocytophilum by affinity purification and proteomics.

Authors:  Yan Ge; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2007-08-31       Impact factor: 3.490

7.  Four VirB6 paralogs and VirB9 are expressed and interact in Ehrlichia chaffeensis-containing vacuoles.

Authors:  Weichao Bao; Yumi Kumagai; Hua Niu; Mamoru Yamaguchi; Koshiro Miura; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2008-10-24       Impact factor: 3.490

8.  Epidemiology and Genetic Diversity of Anaplasma phagocytophilum in the San Francisco Bay Area, California.

Authors:  Nathan C Nieto; Daniel J Salkeld
Journal:  Am J Trop Med Hyg       Date:  2016-05-02       Impact factor: 2.345

9.  Proteomic identification of a novel Anaplasma phagocytophilum DNA binding protein that regulates a putative transcription factor.

Authors:  Xueqi Wang; Takane Kikuchi; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2007-05-04       Impact factor: 3.490

10.  Diminished hematopoietic activity associated with alterations in innate and adaptive immunity in a mouse model of human monocytic ehrlichiosis.

Authors:  Katherine C MacNamara; Rachael Racine; Madhumouli Chatterjee; Dori Borjesson; Gary M Winslow
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.